Showing 191-200 of 3552 results for "".
Benchside Dispatches: Pruritus
https://practicaldermatology.com/topics/practice-management/benchside-dispatches-pruritus/20926/An interview with Gil Yosipovitch, MDWomen in Dermatology: Melissa Kanchanapoomi Levin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-melissa-kanchanapoomi-levin-md/23063/Women in Dermatology: Amy Brodsky, MD, FAAD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-amy-brodsky-md-faad/23470/The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Benchside Dispatches Psoriasis
https://practicaldermatology.com/topics/psoriasis/benchside-dispatches-psoriasis/20922/An interview with Alice Gottlieb, MD, PhDPhysician Spotlight: Robert S. Kirsner, MD, PhD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-robert-s-kirsner-md-phd-faad/20319/It's time to get wound up about wound care.Physician Spotlight: Nehal N. Mehta, MD, MSCE, FAHA
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-nehal-n-mehta-md-msce-faha/20442/Psoriasis comorbidities: Is extinguishing systemic inflammation the solution?Physician Spotlight: Andrew C. Krakowski, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-andrew-c-krakowski-md/20842/Effector Cell Response Inhibitors
https://practicaldermatology.com/series/c-suite-chats/effector-cell-response-inhibitors/48960/Excellergy cofounder Alexander Eggel, PhD, and CEO Todd Zavodnick discuss a recent Journal of Allergy and Clinical Immunology article validating the trifunctional mechanism of action of effector cell response inhibitors (ECRIs) for the treatment of allergic diseases, including chronic spontaneous urNordlys™: A Foundational Platform For Your Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/nordlys-a-foundational-platform-for-your-practice/19628/Don’t miss this informative webinar with E. Victor Ross, MD about his experience with the Nordlys system. Nordlys includes 3 foundational technologies: Ellipse IPL, Frax 1550, and Nd:Yag 1064. The benefits of narrowband IPL with dual filters and sub-millisecond pulses will be examined. Dr. Ross will